Our Pricing

Acid Reflux Treatment Dosage: Complete Guide

Published on: June 03, 2026

Understanding acid reflux treatment dosage UK guidelines is essential for effective symptom control and healing. At Cured Pharmacy, our UK-registered clinical team provides personalised dosage recommendations for proton pump inhibitors (PPIs) and other acid reflux treatments, with transparent pricing from £9.99 and free online consultations.

Understanding PPI Dosage Strengths for Acid Reflux

Proton pump inhibitors remain the gold standard for treating gastro-oesophageal reflux disease (GORD) and acid reflux in the UK [1]. These medications work by blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells, reducing stomach acid production by up to 90% within 24 hours of the first dose [1].

The most commonly prescribed PPIs in the UK include omeprazole (10mg, 20mg), lansoprazole (15mg, 30mg), esomeprazole (20mg, 40mg), and pantoprazole (20mg, 40mg). Each medication has specific dosage protocols based on the severity of symptoms, whether you're treating acute reflux or maintaining long-term control [2].

Clinical trials demonstrate that standard-dose PPI therapy heals oesophagitis in approximately 80-85% of patients within 8 weeks, with higher doses reserved for severe cases or Barrett's oesophagus [1][2]. Your UK prescriber will determine the appropriate starting dose based on your symptom frequency, endoscopy findings if available, and response to previous treatments.

Omeprazole Dosage: 10mg vs 20mg for Acid Reflux

Omeprazole remains one of the most prescribed acid reflux medications in the UK, available from £9.99 at Cured Pharmacy. The standard therapeutic dose for treating symptomatic GORD is 20mg once daily, typically taken 30 minutes before breakfast for optimal acid suppression [3].

For mild, intermittent heartburn, a lower 10mg dose may provide sufficient relief when taken as needed or for short courses of 2-4 weeks. However, patients with erosive oesophagitis or frequent symptoms (more than twice weekly) generally require the full 20mg dose for 4-8 weeks to achieve mucosal healing [3].

Maintenance therapy after initial healing typically involves stepping down to the lowest effective dose — often 10mg daily or 20mg on alternate days. Some patients achieve symptom control with on-demand dosing, taking 10-20mg only when symptoms occur, though this approach is less effective for preventing oesophageal damage in severe cases [2][3].

When to Consider Higher Doses

Patients who don't respond adequately to standard 20mg omeprazole may benefit from dose escalation to 40mg daily or switching to an alternative PPI like esomeprazole 40mg. Clinical studies show that approximately 10-15% of GORD patients require higher doses or twice-daily dosing for adequate acid control [2]. Your UK prescriber will assess your response after 4 weeks and adjust accordingly.

Lansoprazole and Esomeprazole Dosage Protocols

Lansoprazole is available in 15mg and 30mg strengths, with the standard treatment dose being 30mg once daily for 4-8 weeks in symptomatic GORD [4]. This medication offers the advantage of orodispersible formulations (Zoton FasTab), which dissolve on the tongue without water — particularly useful for patients with swallowing difficulties.

Esomeprazole, the S-isomer of omeprazole, demonstrates superior acid suppression at equivalent doses due to more favourable pharmacokinetics [5]. The standard dose is 20mg once daily for reflux oesophagitis, with 40mg reserved for severe cases or those requiring intensive healing. Clinical trials show esomeprazole 40mg achieves healing rates of 90-95% at 8 weeks, slightly higher than other PPIs [5].

At Cured Pharmacy, lansoprazole capsules start from £9.99 and esomeprazole from £9.99, with dosage selection determined during your free clinical assessment. Maintenance doses typically involve stepping down to 15mg lansoprazole or 20mg esomeprazole once healing is confirmed.

Pantoprazole Dosage Considerations

Pantoprazole offers an alternative for patients who experience side effects with other PPIs or require a different pharmacokinetic profile. Standard dosing is 20mg daily for mild-moderate reflux and 40mg for erosive oesophagitis, available from £9.99. The gastro-resistant formulation ensures the active ingredient reaches the small intestine intact, where it's absorbed and activated in the acidic environment of parietal cells [4].

Dosage Timing and Administration for Maximum Effectiveness

The timing of PPI administration significantly impacts therapeutic efficacy. PPIs work by irreversibly binding to actively secreting proton pumps, so they're most effective when taken 30-60 minutes before the first meal of the day, when parietal cells are most active [1][3].

For patients with nocturnal symptoms or breakthrough reflux, splitting the dose to twice daily (morning and evening, before meals) may provide better 24-hour acid control. However, this approach should only be implemented under prescriber guidance, as it increases the total daily dose and potential for side effects [2].

Consistency is crucial — taking your PPI at the same time each day maintains stable acid suppression. Missing doses or irregular timing can lead to 'acid rebound' where symptoms return more severely. If you miss a dose, take it as soon as you remember unless it's nearly time for the next dose; never double up to compensate [3].

Adjusting Dosage Based on Treatment Response

Initial treatment typically lasts 4-8 weeks, after which your UK prescriber will assess symptom resolution and determine the next steps. Approximately 70-80% of patients achieve complete symptom relief on standard-dose PPI therapy within this timeframe [2][4].

If symptoms persist after 4 weeks on standard doses, options include increasing to a higher dose, switching to an alternative PPI with different pharmacokinetics, or adding an H2 receptor antagonist at bedtime for nocturnal acid breakthrough. Persistent symptoms despite optimal PPI therapy warrant investigation for non-acid reflux, bile reflux, or functional dyspepsia [4].

Once symptoms are controlled, the goal is to step down to the lowest effective maintenance dose. This might involve reducing from 40mg to 20mg, switching from daily to alternate-day dosing, or transitioning to on-demand therapy. NICE guidelines recommend regular medication reviews to prevent unnecessary long-term PPI use, as prolonged high-dose therapy carries risks including nutrient malabsorption and increased fracture risk [6].

When to Seek Medical Review

Contact your prescriber if you experience new symptoms such as difficulty swallowing, unintentional weight loss, persistent vomiting, or blood in stools whilst on acid reflux treatment. These 'alarm symptoms' require urgent investigation to rule out serious underlying conditions. Similarly, if your usual dose stops controlling symptoms or you find yourself needing to increase doses frequently, a thorough medical review is essential [6].

Comparing Treatment Options and Choosing the Right Dosage

Whilst all PPIs share the same mechanism of action, individual response varies based on genetic factors affecting drug metabolism, particularly CYP2C19 enzyme activity. Some patients are 'rapid metabolisers' who break down certain PPIs quickly, requiring higher doses or alternative medications [5].

Brand-name options like Losec (omeprazole) and Nexium (esomeprazole) contain identical active ingredients to generic versions but may use different excipients or formulations. At Cured Pharmacy, both generic and branded options are available, with generics offering the same therapeutic efficacy at lower cost — omeprazole starts from £9.99 compared to Losec at £9.99.

Your UK prescriber will consider factors including symptom severity, previous treatment response, concurrent medications that may interact with specific PPIs, and cost-effectiveness when recommending the optimal dosage regimen. All prescription treatments require completion of a free online clinical assessment, which typically takes under 3 minutes and ensures safe, appropriate prescribing tailored to your individual needs.

Scientific References

1. Strand, D. S., Kim, D., & Peura, D. A. (2017). 25 Years of Proton Pump Inhibitors: A Comprehensive Review. Gut and Liver, 11(1), 27–37. https://doi.org/10.5009/gnl15502 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2014). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184). NICE. https://www.nice.org.uk/guidance/cg184 [accessed 13 August 2026]
3. Katz, P. O., Gerson, L. B., & Vela, M. F. (2013). Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology, 108(3), 308–328. https://doi.org/10.1038/ajg.2012.444 [accessed 13 August 2026]
4. Kirchheiner, J., Glatt, S., Fuhr, U., et al. (2009). Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology, 65(1), 19–31. https://doi.org/10.1007/s00228-008-0576-5 [accessed 13 August 2026]
5. Rohss, K., Lind, T., & Wilder-Smith, C. (2004). Esomeprazole 40 mg Provides More Effective Intragastric Acid Control Than Lansoprazole 30 mg, Omeprazole 20 mg, Pantoprazole 40 mg and Rabeprazole 20 mg in Patients with Gastro-oesophageal Reflux Symptoms. European Journal of Clinical Pharmacology, 60(8), 531–539. https://doi.org/10.1007/s00228-004-0804-6 [accessed 13 August 2026]
6. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors in long-term use: reports of hypomagnesaemia. Drug Safety Update, 5(11), A1. https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia [accessed 13 August 2026]
7. NHS. (2026). Heartburn and acid reflux. https://www.nhs.uk/conditions/heartburn-and-acid-reflux/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.